Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APREPRU
DRKS00005594Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aprepitant in prurigo nodularis (PN) and chronic pruritus (CP) (2 arms), sponsored by Universitätsklinikum Münster. Started Jan 2014; status: completed.
02
Drugs
aprepitant
03
Conditions
prurigo nodularis (PN)chronic pruritus (CP)
Beyond the preview
Go deeper on DRKS00005594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005594.